AIX 9.01 ▲0.33% ALU 0.88 ▼-2.22% DN1 99.70 ▼-0.09% EMUCA 0.89 KIT 1.90 ▲0.00% KKC 2.11 ▲0.00% LF1 1.92 ▲0.79% MBG 0.14 ▲0.00% MRE 1.88 ▼-0.53% PCI 1.09 ▼-0.91% PCX 1.99 ▼-0.75% RF1 3.52 ▼-0.28% SET 2.14 ▼-0.47% TET 0.22 ▼-2.22% WMX 1.69 ▼-1.17% BST 0.30 ▲3.45% CTS 0.56 ▲1.82% EFR 0.00 ▲0.00% AIX 9.01 ▲0.33% ALU 0.88 ▼-2.22% DN1 99.70 ▼-0.09% EMUCA 0.89 KIT 1.90 ▲0.00% KKC 2.11 ▲0.00% LF1 1.92 ▲0.79% MBG 0.14 ▲0.00% MRE 1.88 ▼-0.53% PCI 1.09 ▼-0.91% PCX 1.99 ▼-0.75% RF1 3.52 ▼-0.28% SET 2.14 ▼-0.47% TET 0.22 ▼-2.22% WMX 1.69 ▼-1.17% BST 0.30 ▲3.45% CTS 0.56 ▲1.82% EFR 0.00 ▲0.00%

MVF Monash IVF Group Limited

Healthcare · Diagnostics & Research · website · 892 employees
$0.69
52wk 0.57 – 0.90
Overall
Value
Growth
Health
Quality
Momentum
Dividend
Price
About Monash IVF Group Limited

Monash IVF Group Limited engages in the provision of assisted reproductive and specialist women imaging services in Australia and Malaysia. It offers diagnostic obstetric, gynecological ultrasound, and fertility treatment services. It also provides tertiary level prenatal diagnostic, and IVF treatment services. Monash IVF Group Limited was incorporated in 2014 and is headquartered in Richmond, Australia.

Fundamental trends
Financial statements
Loading…
Key metrics
Market cap
$266.90M
P/E (trailing)
17.12
P/E (forward)
13.50
EPS (trailing)
0.04
Dividend yield
5.5%
Payout ratio
68.4%
Beta
0.38
EV / EBITDA
10.19
Price / Book
1.05
ROE
6.2%
Operating margin
10.8%
Net margin
5.6%
Total cash
$8.15M
Total debt
$197.70M
Current ratio
0.82
Debt / Equity
0.77
Free cash flow
$648,000
Avg volume
519,261
Latest annual results (FY ending 30 Jun 2024)
  • Revenue$254.96M
  • Gross profit$228.35M
  • Operating income-$5.61M
  • Net income-$6.53M
  • Diluted EPS-0.02
  • Free cash flow$30.85M
  • Net debt$124.04M
Sector peers (Healthcare)
TickerMkt cap P/EScore
CSL $59.53B 14.0
RMD $43.89B 20.4
SIG $34.28B 59.4
FPH $20.25B 52.2
PME $17.21B 73.5
SHL $10.79B 19.7
RHC $10.13B 34.8
COH $7.90B 22.9